Allison Luo
Direttore Tecnico/Scientifico/R&S presso PROMETHEUS BIOSCIENCES, INC.
Posizioni attive di Allison Luo
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| PROMETHEUS BIOSCIENCES, INC. | Direttore Tecnico/Scientifico/R&S | 01/08/2018 | - |
| BIORA THERAPEUTICS, INC. | Corporate Officer/Principal | 01/06/2017 | - |
Storia della carriera di Allison Luo
Precedenti posizioni note di Allison Luo
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Direttore/Membro del Consiglio | 01/09/2006 | 01/10/2014 |
| IVERIC BIO, INC. | Corporate Officer/Principal | 01/09/2015 | - |
| ABBOTT LABORATORIES | Direttore Tecnico/Scientifico/R&S | - | - |
Formazione di Allison Luo
| Northwestern University | Doctorate Degree |
Statistiche
Distribuzione geografica
| Stati Uniti | 7 |
Posizioni
| Chief Tech/Sci/R&D Officer | 2 |
| Corporate Officer/Principal | 2 |
| Doctorate Degree | 1 |
Settori
| Health Technology | 5 |
| Consumer Services | 2 |
| Health Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 3 |
|---|---|
| ABBOTT LABORATORIES | Health Technology |
| BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
| BIORA THERAPEUTICS, INC. | Health Services |
| Aziende private | 2 |
|---|---|
Prometheus Biosciences, Inc.
 Prometheus Biosciences, Inc. BiotechnologyHealth Technology Prometheus Biosciences, Inc. engages in operation of a biopharmaceutical company. It focuses on the discovery, development, and commercialization of novel precision therapeutics and companion diagnostics for patients living with unmet needs in gastroenterology and autoimmune diseases. The company was founded by Scott Glenn and Stephan Targan on October 26, 2016 and is headquartered in San Diego, CA . | Health Technology |
IVERIC bio, Inc.
 IVERIC bio, Inc. Pharmaceuticals: GenericHealth Technology IVERIC bio, Inc. operates as a biopharmaceutical company. The firm engages in discovering, developing and commercializing novel therapeutics to treat ophthalmic diseases, with a focus on age-related and orphan retinal diseases. Its product candidates include Zimura and Gene Therapy. The company was founded by David R. Guyer and Samir Chandrakant Patel on January 5, 2007 and is headquartered in Parsippany, NJ. | Health Technology |
- Borsa valori
- Insiders
- Allison Luo
- Esperienza